Skip to main content
. 2021 Oct 9;10:123. doi: 10.1186/s40249-021-00908-2

Table 3.

Pooled estimates of odds ratio and corresponding 95% confidence intervals of patient demographic characteristics and severe dengue

Predictors Number of studies Pooled Heterogeneity test
OR (95% CI) I2 (%) P-value
Demography
 Children 22 1.96 (1.22–3.13) 90.00 < 0.001
 Female 114 1.20 (0.79–1.82) 80.3 < 0.001
 Secondary infection 29 3.23 (2.28–4.57) 33.20 0.044
Co-morbidities
 Diabetes 10 2.88 (1.72–4.81) 40.9 0.085
 Cardiovascular disease 4 2.27 (0.38–13.71) 70.8 0.016
 Obesity 5 0.76 (0.41–1.40) 32.9 0.202
 Renal disease 4 4.54 (1.55–13.31) 45.1 0.162
 Hypertension 9 1.82 (0.98–3.37) 63.1 0.006
Warning signs
 ↑Hct & ↓Plt* 7 5.13 (1.61–16.34) 88.1 < 0.001
 Abdominal pain 55 2.00 (1.49–2.68) 70.9 < 0.001
 Vomiting 53 1.80 (1.43–2.26) 62.8 < 0.001
 Lethargy 10 2.73 (1.05–7.10) 85.1 < 0.001
 Hepatomegaly 47 5.92 (3.29–10.65) 89.3 < 0.001
 Ascitis 22 6.30 (3.75–10.60) 67.7 < 0.001
 Pleural effusion 25 5.72 (3.24–10.10) 76.3 < 0.001
 Gum bleeding 12 2.00 (0.86–4.66) 56.4 0.008
 Epistaxis 11 1.85 (0.72–4.70) 64.4 0.002
 Hemetemesis 5 12.35 (4.97–30.72) 52 0.080
 Melena 9 4.05 (1.64–10.00) 78.1 < 0.001
 Skin bleeding 4 1.38 (0.47–4.06) 73.5 0.010
 GI bleeding 5 9.49 (2.75–32.70) 78.4 0.001

*Increase in haematocrit values with concurrent decrease in platelet count

OR odd ratio, CI confidential interval